Literature DB >> 30551533

RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma.

Defeng Qi1, Mingming Wang2, Fenghua Yu3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “In almost all papers, Western blot panels within the same figure, and across figures and papers, appear to share the same background, while the bands are regularly spaced, all have similar rounded edges without the usual smudges and specks, and with some bands showing a recognizable “jumping sardine” shape”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  PI3K/AKT/mTOR; RUNX2; Retinoblastoma; lncRNA-H19; microRNA-143

Mesh:

Substances:

Year:  2018        PMID: 30551533     DOI: 10.1016/j.biopha.2018.10.096

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Long non-coding RNA UCA1 promotes retinoblastoma progression by modulating the miR-124/c-myc axis.

Authors:  Lan Wang; Mingxing Wu; Xiyuan Zhou
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  LncRNA H19 Regulates BMP2-Induced Hypertrophic Differentiation of Mesenchymal Stem Cells by Promoting Runx2 Phosphorylation.

Authors:  Guangming Dai; Haozhuo Xiao; Chen Zhao; Hong Chen; Junyi Liao; Wei Huang
Journal:  Front Cell Dev Biol       Date:  2020-07-29

3.  Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.

Authors:  Hui Zhou; Weifeng Shen; Hongxing Zou; Qingshan Lv; Pingyang Shao
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

4.  LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network.

Authors:  Min-Er Zhong; Yanyu Chen; Guannan Zhang; Lai Xu; Wei Ge; Bin Wu
Journal:  Cancer Cell Int       Date:  2019-05-30       Impact factor: 5.722

Review 5.  Targeting PI3K in cancer: mechanisms and advances in clinical trials.

Authors:  Jing Yang; Ji Nie; Xuelei Ma; Yuquan Wei; Yong Peng; Xiawei Wei
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

6.  Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression.

Authors:  Yi Dong; Guangming Wan; Panshi Yan; Cheng Qian; Fuzhen Li; Guanghua Peng
Journal:  Aging (Albany NY)       Date:  2020-05-05       Impact factor: 5.682

7.  Long Noncoding RNA HEIH Promotes Proliferation, Migration and Invasion of Retinoblastoma Cells Through miR-194-5p/WEE1 Axis.

Authors:  Sheng Gao; Qingxia Chu; Xia Liu; Xia Zhao; Libao Qin; Guoliang Li; Qinghuai Liu
Journal:  Onco Targets Ther       Date:  2020-11-23       Impact factor: 4.147

8.  LINC00202 promotes retinoblastoma progression by regulating cell proliferation, apoptosis, and aerobic glycolysis through miR-204-5p/HMGCR axis.

Authors:  Aimin Wu; Xuewei Zhou; Linglong Mi; Jiang Shen
Journal:  Open Life Sci       Date:  2020-06-30       Impact factor: 0.938

9.  Knockdown of lncRNA HOTTIP Inhibits Retinoblastoma Progression by Modulating the miR-101-3p/STC1 Axis.

Authors:  XiangWen Yuan; Zhaoyan Sun; Congxian Cui
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

10.  Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.

Authors:  Yuyang Zeng; Tao He; Juejun Liu; Zongyuan Li; Feijia Xie; Changzheng Chen; Yiqiao Xing
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.